Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Otitis media.

Michael E Pichichero1, Janet R Casey

  • 1Elmwood Pediatric Group, University of Rochester Medical Center, Rochester, NY 14642, USA. michael_pichichero@urmc.rochester.edu

Expert Opinion on Pharmacotherapy
|August 2, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence and Cost of Otitis Media in High-income and Low- and Middle-income Countries.

The Pediatric infectious disease journal·2026
Same author

Variability in Vaccine Response and Trajectory in Early Childhood and Association With Demographic Variables, Antibiotic Exposure, and Infection Proneness.

The Journal of infectious diseases·2025
Same author

Serotype 3 Antibody Response and Antibody Functionality Compared to Serotype 19A Following 13-Valent Pneumococcal Conjugate Immunization in Children.

The Pediatric infectious disease journal·2023
Same author

Variability of Vaccine Responsiveness in Young Children.

The Journal of infectious diseases·2023
Same author

Variability of vaccine responsiveness in early life.

Cellular immunology·2023
Same author

Very early life microbiome and metabolome correlates with primary vaccination variability in children.

mSystems·2023
Same journal

Pharmacotherapeutic interventions for pediatric ulcerative colitis.

Expert opinion on pharmacotherapy·2026
Same journal

The rise and fall of TRPV1-targeted analgesia in osteoarthritis: a critical appraisal.

Expert opinion on pharmacotherapy·2026
Same journal

Dopamine transporter and beyond: evolving targets and combination strategies in stimulant use disorder.

Expert opinion on pharmacotherapy·2026
Same journal

GnRH antagonists for the treatment of fibroids and adenomyosis, current evidence and future perspectives.

Expert opinion on pharmacotherapy·2026
Same journal

Pharmacotherapeutic strategies for the management of congenital adrenal hyperplasia.

Expert opinion on pharmacotherapy·2026
Same journal

CURRENT ADVANCES IN PHARMACOTHERAPEUTIC STRATEGIES FOR THE TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTIONS.

Expert opinion on pharmacotherapy·2026
See all related articles

Acute otitis media (OM) in children is often caused by bacteria like Streptococcus pneumoniae. Antibiotic therapy, particularly short-course treatments, improves symptom resolution, but careful diagnosis considering pathogen resistance is crucial.

Area of Science:

  • Otolaryngology
  • Pediatrics
  • Infectious Diseases

Background:

  • Acute otitis media (OM) commonly involves bacterial pathogens, predominantly Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
  • OM classification includes uncomplicated, persistent, recurrent, and chronic forms, influenced by patient factors and day-care exposure.

Purpose of the Study:

  • To review the management of acute otitis media, focusing on pathogen distribution, antimicrobial susceptibility, and therapeutic responses.
  • To highlight the role of antibiotic selection based on pharmacokinetic/pharmacodynamic principles and resistance mechanisms.

Main Methods:

  • Review of clinical trials and meta-analyses on acute otitis media treatment.
  • Analysis of factors influencing pathogen distribution and antimicrobial susceptibility in children.

Related Experiment Videos

Main Results:

  • While OM can resolve naturally, antimicrobials improve symptom and effusion resolution.
  • Antibiotic choice (aminopenicillins, cephalosporins, macrolides) impacts efficacy against resistant pathogens.
  • Short-course therapy is increasingly supported by compelling data.

Conclusions:

  • Best-practice management involves accurate diagnosis, consideration of major pathogens and resistance, and antibiotic therapy.
  • Antibiotic selection should prioritize activity against drug-resistant S. pneumoniae and beta-lactamase-producing Gram-negatives.
  • Tympanocentesis is a recognized diagnostic and therapeutic procedure.